BCDA maintains an extensive roster of CNF (Clearing and Forwarding) agents representing both prominent and emerging pharmaceutical companies, regardless of their scale. Within this framework, BCDA wields the authority to address and resolve a spectrum of issues that may arise in connection with CNF agents. This distinctive role encompasses several pivotal aspects

Comprehensive Oversight of CNF Agents: BCDA assumes the responsibility of meticulously cataloging and overseeing CNF agents affiliated with both large and small pharmaceutical companies. This comprehensive database ensures that the interests of all stakeholders are duly considered.

Issue Resolution Authority: BCDA possesses the power and capacity to proactively tackle a diverse range of issues pertinent to CNF agents. Whether a pharmaceutical company encounters operational challenges or a CNF agent faces obstacles in their role, BCDA is poised to step in as an effective mediator and problem-solving entity.

Support for Companies: In instances where pharmaceutical companies grapple with operational hurdles or difficulties within their supply chain, BCDA readily extends its assistance. This collaborative approach is instrumental in overcoming barriers that may impede the smooth functioning of the pharmaceutical business.

Mediation for CNF Agents: BCDA also serves as an essential mediator when CNF agents encounter difficulties or disputes. Its intervention not only aids in resolving conflicts but also offers crucial support to CNF agents, helping them navigate complex challenges effectively.

Holistic Industry Growth: BCDA's overarching mission is to foster the holistic growth of the pharmaceutical sector. It operates with the conviction that when all facets of the pharmaceutical industry prosper, it benefits not only pharmaceutical companies and CNF agents but also the broader ecosystem, including healthcare providers and consumers.

BCDA plays a central role in the pharmaceutical industry by managing and supporting CNF agents, irrespective of the size of the pharmaceutical companies they represent. Its authority to address issues and act as a mediator underscores its commitment to ensuring the seamless operation of the pharmaceutical business. The overarching goal of BCDA is to facilitate the holistic growth of the pharmaceutical industry, creating a thriving ecosystem where all stakeholders derive mutual benefits and contribute to the advancement of healthcare